Pharmaceuticals use a study for PR

SACRAMENTO: After weeks of adverse PR fueled by charges that it gouges prices for prescription drugs, the pharmaceutical industry scored some canny PR last week with the release of a comparison study showing that pharmacies sell drugs at widely differing prices.

SACRAMENTO: After weeks of adverse PR fueled by charges that it gouges prices for prescription drugs, the pharmaceutical industry scored some canny PR last week with the release of a comparison study showing that pharmacies sell drugs at widely differing prices.

SACRAMENTO: After weeks of adverse PR fueled by charges that it gouges prices for prescription drugs, the pharmaceutical industry scored some canny PR last week with the release of a comparison study showing that pharmacies sell drugs at widely differing prices.

The study was released by the non-profit International Patient Advocacy Association (IPAA) and the non-profit TMJ Society. It comes at a time when the pharmaceutical industry is under fire from Al Gore for profiting unfairly from high margins. The IPAA receives monetary grants from the Pharmaceutical Research and Manufacturers Association of America, an industry lobbying group composed of major pharmaceutical companies.

The study showed that drug prices for the nation's top four bestselling drugs varied between 31% and 42% at independent, chain and discount pharmacies in 19 California cities and towns.

Kassy Perry, president of Sacramento-based healthcare boutique Perry Communications, said that IPAA founder Lenny Van Pelt initiated the study because of widespread media reports that seniors were heading to Canada and Mexico to purchase cheaper drugs. Perry is assisting the IPAA with publicity for the study and has already scored a hit in The Wall Street Journal.





Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

Would you like to post a comment?

Please Sign in or register.